Reta-Peptide
Tirzepatide
Finnrick tested 3 samples of Tirzepatide (GLP-1 and GIP antagonist) from Reta-Peptide between 20 Jun 2025 and 25 Jul 2025. Test scores average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).
Finnrick Rating™
Tentative Rating
Reta-Peptide
Tirzepatide
Tested 3 Samples
Last test 25 Jul 2025
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Tirzepatide tests from top-rated vendors:
All Tirzepatide tests from Reta-Peptide
Samples are tested in commercial labs
Tests Count
3
Scores
AVGMINMAX
Last
25 Jul 2025
First
20 Jun 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 25 Jul 2025 | View | 20mg | 19.500mg | -2.5% | 99.95% | (no batch ID) | White Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 16 Jul 2025 | View | 30mg | 30.300mg | +1.0% | 99.87% | (no batch ID) | No Label / Silver Crimp / Pink Cap | Lab E | Public | |
| 20 Jun 2025 | View | 20mg | 18.700mg | -6.5% | 99.83% | (no batch ID) | White Label / Silver Crimp / Purple Cap | Lab E | Public | |